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Abstract 
Leptospirosis is a neglected zoonotic disease that disproportionately affects poor 
populations in the world. Prevalence data in human populations in pastoral communities 
has been shown to be high. The disease is therefore contributing to an unknown toll on 
livestock productivity as well as human health in these areas. Rodent populations in 
irrigated areas of Kenya have also seen a rise and this could lead to an increase 
transmission of rodent-borne diseases. This pilot study therefore aimed at demonstrating the 
presence of the bacteria in rodent carriers in Tana River and Garissa counties of Kenya, 
areas that are characterized by irrigation and pastoral activities respectively.  
Kidney and blood samples from 67 rodents previously collected from these areas (mainly 
mice and multimammate rats) were analyzed using PCR. Prevalence of leptospires in 
rodent carriers was found to be 41.8% (28/67). Prevalence in the towns was: 16% (4/25) in 
Bura; 42% (8/19) in Hola; 82% (9/11) in Ijara and 58% (7/12) in Sangailu. Prevalence was 
found to be influenced with the area of sampling, with rodents from the pastoral areas being 
more likely to have the bacteria than those from the irrigated areas (Odds Ratio = 6.095). 
Prevalence showed no association with the species and age of rodents. Sequencing data 
revealed the species in circulation among rodents is Leptospira interrogans.  
This pilot study is one of the few to demonstrate the bacteria in rodent carriers in North-
Eastern Kenya, which illustrates the underplayed public health importance of the disease in 
this part of Kenya. The high rodent prevalence of these bacteria poses risk of transmission 
of the disease in animal and human populations. These results demonstrate the need for 
policy makers to consider disease emergence and transmission in these marginalized parts 
of Kenya. More epidemiological knowledge of the disease like circulating serotypes and 
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role of animal hosts in the area will greatly aid in forming public health policy aimed at 
controlling the disease. 
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1. Introduction 
Leptospirosis is a disease that affects animals and human beings. The aetiological agent for 
this disease is all pathogenic bacteria of the genus Leptospira; family Leptospiraceae and 
order Spirochaetales. Leptospira bacteria are largely divided into pathogenic and non-
pathogenic strains  based on the old serological classification (Hovind-Hougen, 1979), with 
an extra intermediate (opportunistic) group being included in the recent genotypic 
classification (Levett, 2015). The bacteria can infect all mammals. 
Following infection, the bacteria inhabit the renal tubules and urogenital tract where they 
multiply and are ultimately shed in the urine of the host animal. Human infection can be 
brought about by direct or indirect contact with urine from an infected animal  though there 
are other routes of infection (Bharti et al., 2003). 
Leptospirosis is a systemic zoonotic disease. It mainly affects humans and domestic 
animals such as cattle, swine and dogs (Adler & de la Peña Moctezuma, 2010). The disease 
in humans presents mainly as either a biphasic illness or the fulminant form of the disease. 
The biphasic illness is characterized by an undifferentiated febrile syndrome and pyuria 
while the fulminant form, termed Weil’s disease, is characterized by renal and hepatic 
insufficiencies as well as other hematological manifestations such as thrombocytopenia 
(Bharti et al., 2003). 
The most important carriers of the Leptospira bacteria are rodents, which pass the disease 
to domestic and wild animals directly or indirectly through urine contamination of shared 
water sources/bodies. Knowledge gaps have curtailed efforts to give current figures of the 
burden of leptospirosis in many parts of the world. Estimates however place it to have a 
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global burden 70% more than that of cholera (Torgerson, Hagan, Costa, et al., 2015), 
making it an important bacterial zoonosis to be considered in global health. The disease 
also decreases livestock productivity and causes considerable reproductive wastage. Few 
studies exist on the impact that animal leptospirosis has on productivity of animals of 
economic importance and low-cost interventions needed to reduce transmission of the 
infection between animal hosts and human populations (Schneider, Jancloes, Buss, et al., 
2013). 
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2. Leptospirosis in the world 
2.1 Global Outlook 
Leptospirosis is regarded as having the widest geographical reach of all of the zoonotic 
diseases (Evangelista & Coburn, 2010). Recent modelling studies have revealed that the 
disease is a leading contributor of human mortalities and morbidities in the world (Costa et 
al., 2015)  with most of these cases found to be in the most resource-scarce regions. The 
disease is thought to contribute 2.90 million Disability-Adjusted Life Years (DALYs) 
globally per annum (Torgerson, Hagan, Costa, et al., 2015). Leptospirosis-HIV co-
infections have also been recorded in many parts of the world with the severity ranging 
from mild and resolving illness to fulminant disease, causing high mortalities in some of 
these patients (Kuppalli, Chandrasekaran, Rio, et al., 2011; Biggs, Galloway, Bui, et al., 
2013; Jones & Kim, 2001; Ganoza, Segura, Swancutt, et al., 2005; Pai, 2013). The 
interaction of leptospirosis with key infectious diseases in global health needs further 
investigation as it may contribute significant disease burden in many immunosuppressed 
patients in the world. 
Environmental drivers interplaying with changes in climate, and certain anthropogenic 
factors, have been demonstrated to lead to incidences of leptospirosis in many parts of the 
world. For instance, higher than normal rainfall and extreme weather events are natural 
disasters that can cause a rise in rodent populations, as well as those of other animal 
reservoirs. This is due to the scattering of debris and garbage, interference of sewerage 
systems as well as the increased growth of vegetation leading to increased food availability. 
Flood waters that drive reservoir animals out of their habitats can lead them to move to 
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human populations and increase human-animal contact. This can ephemerally lead to 
increased transmission of the disease (Lau et al., 2010). 
Conversely, a decrease in rainfall can also increase the human-to-animal contact by 
reducing the water available on the surface as well as forcing rodents into human 
habitations in order to forage for food (Cook et al., 2008). The interaction of these factors is 
therefore complex and dynamic in nature. 
  
5 
 
2.2 Africa 
Leptospirosis poses a disease burden in Africa that is not fully elucidated due to the lack of 
adequate data  (Costa et al., 2015). A lack of adequate diagnosis and surveillance has 
hindered investigations into the extent that leptospirosis impacts upon human health and 
livestock productivity.  
Leptospirosis is regarded as a neglected zoonotic disease (NZD) (WHO, 2011), and 
therefore a disease that disproportionately affects the impoverished and marginalized 
populations due to its characteristic association with poverty. With the development of 
rapid diagnostic tests for malaria, more and more febrile illnesses in sub-Saharan Africa are 
being recognized as non-malarial (de Vries et al., 2014). Some of these previously mis-
diagnosed infections may be as a result of leptospirosis, the symptoms of which can be 
similar to those of malaria.  
A recent systematic review (Allan et al., 2015) compared the knowledge about human 
acute leptospirosis as well as the cases of the infection in animal hosts in Africa. A 
summary of the data gathered from present literature using preferred reporting items for 
systematic reviews and meta-analyses (PRISMA) guidelines is summarized in Table 1 
below. This review only sought to highlight current cases and therefore excluded studies 
that; didn’t include original research data, didn’t focus on naturally-occurring human or 
animal leptospirosis, used serological diagnostic methods, used experimental animal 
inoculations, didn’t met the case definitions and those that reported of returning travelers. 
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Table 1: Results of systematic literature review of peer reviewed and grey literature in Africa between 1930 and 2014, 
with the numbers representing the articles identified based on the inclusion criteria used. This has been adapted from 
Allan et al., (2015). 
Region Country 
 
Both animal 
carrier and human 
illness data 
Animal carrier 
data only 
Human data only 
Eastern Africa Comoros 2 - - 
 Kenya 9 - - 
 Madagascar 6 - - 
 Mayotte 3 - - 
 Réunion 5 - - 
 Tanzania 9 - - 
 Zimbabwe - 8 - 
 Mozambique - - 1 
 Seychelles - - 2 
Southern Africa South Africa 14 - - 
 Botswana - 2 - 
Middle Africa Cameroon - 1 - 
 Democratic 
Republic of the 
Congo (DRC) 
- - 3 
 Gabon - - 3 
Western Africa Ghana 4 - - 
 Benin - 1 - 
 Guinea - 1 - 
 Nigeria - 4 - 
 Mali - - 1 
 Senegal - - 3 
Northern Africa Egypt 10 - - 
 Tunisia - 4 - 
 Algeria - - 1 
 Morocco - - 3 
 
The other African countries not included didn’t have data for this infection based on the 
inclusion criterion used. Data from cohort and surveillance studies in the same time period 
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however reveal extensive scientific evidence that the disease is an important contributor of 
febrile illnesses in hospitals across the continent (Allan, Biggs, Halliday, et al., 2015). The 
study also attested to many cases of Leptospira infection in domestic and wild animals 
through the continent, highlighting the need for studies that integrate animal and human 
infections, a one-health approach, to better understand the overall epidemiology of this 
disease in different settings across the continent. This is especially important for a continent 
that has a high number of poor people that depend on livestock (Grace et al., 2012). 
 
2.3 Eastern Africa 
 
2.3.1 Tanzania 
Leptospirosis has been widely reported in Tanzania, which has wider epidemiological data 
than most African countries (Table 1). Confirmed cases of the disease have been reported at 
17.5% (70/400) (Machang’u, 2006) and 8.4% (70/870) (Biggs, Bui, Galloway, et al., 2011) 
among hospital patients in different parts of the country. Febrile patients in Kilosa district 
of Tanzania were recently revealed to have confirmed leptospirosis cases as well (13% 
[26/200]) (Chipwaza et al., 2015). The provisional diagnosis of some of these patients 
suffering from leptospirosis was malaria and other common febrile illnesses. This serves to 
show the under-recognized nature of the disease among febrile patients in the country. Co-
infections of leptospirosis and other febrile illnesses have also been shown in these patients. 
This finding shows how differential diagnosis is difficult without the use of diagnostic tests 
(Chipwaza, Mhamphi, Ngatunga, et al., 2015). 
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Leptospiral antibodies in humans, rodents and various domestic and wild animals in the 
Katavi-Rukwa ecosystem of Tanzania have been shown to be widely prevalent and that 
common serogroups circulate among these hosts (Assenga et al., 2015).  
Leptospira have also been demonstrated directly through molecular techniques and 
indirectly by use of serological techniques in other species in the country such as: rodents 
with 11 % (3/27) prevalence (Mgode, Mhamphi, Katakweba, et al., 2005); pigs with 4.42% 
(17/385) prevalence (Kessy, Machang’u & Swai, 2010); bats at 19.4% (7/36) prevalence 
(Mgode, Mbugi, Mhamphi, et al., 2014); fish at 54.2% (26/48) prevalence (Mgode, 
Mhamphi, Katakweba, et al., 2014); rodents and shrews at 10% (50/500) prevalence 
(Machang’u, 2006); cattle at 30.3% (198/654)  (Schoonman & Swai, 2010); as well as dogs 
and cats (Mgode, Machang’u, Mhamphi, et al., 2015). All these studies therefore point to 
the varied number of animal hosts that commonly interact with humans and that can act as 
transmitters of pathogenic leptospires. 
 
2.3.2 Uganda  
Though Uganda has little published data on this disease in both human and livestock 
populations, efforts still exist to demonstrate the disease in the country.  
A pilot study conducted in Southwestern Uganda that demonstrated an overall 
seroprevalence of 42.39% (39/92) in African buffalo and 29.35% (27/92) in cattle in 
Southwestern Uganda  (Atherstone et al., 2014). Other studies have been done in dogs and 
buffaloes around national parks in Uganda. A seroprevalence of 26.7% (28/105) among 
dogs (Millán, Chirife, Kalema-Zikusoka, et al., 2013) and 0% (0/42) seroprevalence among 
the buffaloes sampled (Kalema-Zikusoka, Bengis, Michel, et al., 2005) was demonstrated 
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in these different studies. These observations show that peri-domestic animals can be a 
potential source of the infection in human populations in the country, a theory that can only 
be corroborated by further investigations with a one-health approach so as to demonstrate 
the role of different animal hosts in the epidemiology of the disease.  
The presence of suitable reservoir hosts, suitable environment for survival of the bacteria 
and the fact that surrounding countries have reported the disease make for a compelling 
argument that the disease is present in the country (Atherstone, Picozzi & Kalema-
Zikusoka, 2014), despite there being no reported human and animal cases (AU-IBAR, 
2016). 
 
2.3.3 Select Eastern African countries 
Little data exists in the other East African countries on leptospirosis. Observational studies 
in Djibouti have shown seroprevalences as high as 84% (26/31) among camels, horses and 
cattle (Roqueplo, Davoust, Mulot, et al., 2011).  
An early study done in all provinces of Sudan on cattle, goats and rats showed 
seroprevalences of 15.3% (175/1142), 13.3% (4/30) and 23.3% (13/56) respectively (El 
Wali, 1980). The presence of the disease in the country was later on demonstrated by  
Sebek et al. (1989) who observed seroprevalences of 54% (n=195) among domestic 
animals and 9.8% (70/771) in wild animals surveyed in a district in Sudan. Rodent species 
collected in this study also showed presence of the bacteria.  
Human populations in Somalia have also shown presence of leptospiral agglutinins in a 
riverine and pastoral region of the country. The overall seroprevalence was found to be 
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50.5% (107/212), with those from the riverine area being 63.5% (68/107) and those from 
the dry area being 37.1% (39/105). The overall seroprevalence in this study was found to be 
generally higher than those found in other parts of the world. The close contact of nomads 
with their animals during cattle-droving, which is common in Somalia, was thought to be a 
risk factor (Cacciapuoti, Nuti, Pinto, et al., 1982). 
Seropositivity has been demonstrated in horses, cows, pigs, goats, sheep, camels and  dogs 
in Ethiopia (Moch, Ebner, Barsoum, et al., 1975). Seroprevalence of human leptospirosis in 
Ethiopia has also been observed to be 47.46% (28/59) among febrile patients. The country 
is thought to have favourable conditions for the incidence and transmission of the disease 
even though having very little documented information about the disease (Yimer, 
Koopman, Messele, et al., 2004). 
 
2.3.4 Kenya 
2.3.4.1 Current outlook on recently published data 
Recent studies in urban, rural and arid areas of Kenya exist and serve to paint a picture on 
what underlying disease burden leptospirosis poses, as well as the diverse geographical 
zones the disease is found in. Most of these studies currently focus on human populations, 
with few focused on animal populations. 
Doctoral work by Cook (2014) was the first in demonstrating Leptospira antibodies among 
slaughterhouse workers at 13.4% (99/738) prevalence in Busia, Kenya. This study also 
demonstrated that leptospirosis is an occupational disease among slaughterhouse workers as 
they had twice the odds of being seropositive for the bacteria than the general population. 
This shows the need for monitoring of other at-risk populations in the country who are not 
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necessarily exposed to rodent-carriers like veterinarians, farmers, water-sports athletes, 
military personnel, among others. 
The importance of the disease in rural Kenya is further illustrated by another study in arid 
and semi-arid lands (ASALs) area of Kenya by Ontiri et al. (2014). The unpublished data in 
this study has cited increase in rodent populations in Tana River county of Kenya due to the 
increased food available in the farms following increased irrigation activity in the area. 
Preliminary data from an epidemiological study in the same study area by Bett et al. (2015) 
has also revealed high seroprevalence of Leptospira antibodies in the human populations. 
The seroprevalence was however even higher in the neighboring pastoral population. This 
demonstrates the need for further investigation of leptospirosis in both of these areas.  
The disease has also been demonstrated in Somali pastoralists in remote, arid Northeast 
Kenya who were positive for Immunoglobulin M (IgM) antibodies with a prevalence of 
25% (3/12) (Ari, Guracha, Fadeel, et al., 2011). Antibodies against leptospirosis in Garissa 
district have also been observed in patients as part of differential diagnosis of rift valley 
fever (RVF). This was during the largest outbreak of RVF in humans ever recorded in East 
Africa at the time (Woods, Karpati, Grein, et al., 2002). 
The public health risk of exposure to the disease in an urban slum area in Kenya was 
demonstrated by Halliday et al. (2013). They demonstrated 18.3% (41/224) prevalence of 
the bacteria among rodents collected in the Kibera settlement area in Nairobi, an area with a 
high number of people with undifferentiated febrile illness.  
Over 161 human cases suspected to be leptospirosis and 8 fatalities were reported by the 
Kenyan Ministry of Health in schools in Western Kenya. These cases are the only reported 
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outbreak cases to the World Health Organisation (WHO) so far (WHO, 2004). Analysis of 
global trend of incidences of the disease has shown that Kenya may have high incidences of 
human leptospirosis, even without studies to estimate the incidence rate in the country 
(Pappas, Papadimitriou, Siozopoulou, et al., 2008). 
The study of leptospirosis and its effects on animal production in the country is not 
comprehensive, though it could contribute to large reproductive losses in animals. About 
27.3% (18/66) of veterinarians perceived the disease to contribute to majority of bovine 
abortions in the former Nakuru district of Kenya (Okumu, 2014). No cases in animals have 
been reported to the World Organisation for Animal Health (OIE) (AU-IBAR, 2016).  
Disease outbreaks in humans in Kenya and other African and Asiatic countries have been 
linked strongly to extreme weather events like flooding, which increases rodent populations 
and offers contaminated flood waters for transmission of the disease (WHO, 2011).  
2.3.4.2 Areas of concern 
Kenya, as with most developing countries, lacks the diagnostic capacity needed to 
adequately control this disease. This coupled with the fact that it is a tropical country makes 
it hard to distinguish leptospirosis from malaria and other febrile illnesses which are 
endemic to this region. This therefore contributes to the under-recognized public health 
concern the disease poses. The disease has already been demonstrated among pastoralist 
communities of Kenya and is likely contributing to an unknown disease burden in their key 
economic resource, their animals. 
The effects that a changing climate has on the incidence of disease are also exacerbated 
with poverty. Anthropogenic activities that drive disease are also leading to increased 
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disease incidence, a challenge that many small-holder farmers who are poor may not have 
capacity to handle (Grace & Bett, 2014). This therefore means that leptospirosis may 
handicap the health and livelihoods of many in communities in the country, some of whom 
do not have access to primary healthcare. 
There is also lack of adequate epidemiological studies that can inform about local serotypes 
as well as the roles of different animal hosts in different parts of the country, all of which 
are important in control of the disease. For instance, very little is known about this disease 
in goats in developing countries (Ellis, 2015), which is a common and important domestic 
animal in Kenya. 
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2.4 Aims 
 
To determine the prevalence of leptospirosis in rodents collected from Tana River and 
Garissa counties of Kenya 
To determine differences in presence of leptospiral bacteria in rodent carriers from irrigated 
and pastoral areas of sampling 
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3.0 Animal leptospirosis  
3.1 Aetiology 
Leptospirosis is caused by pathogenic leptospires. The bacteria are in the phylum 
Spirochaetes, class Spirochaetes, order Spirochaetales, family Leptospiraceae and genus 
Leptospira (Garrity, Bell & Lilburn, 2004). The family Leptospiraceae initially contained 
two genera; Leptospira and Leptonema (Hovind-Hougen, 1979). A third genus, 
Turneriella, was later added to this family due to its genetic relatedness with other 
members of the family (Levett, Morey, Galloway, et al., 2005). The Leptospira genus was 
formerly divided into Leptospira interrogans and Leptospira biflexa species, with the 
former containing all pathogenic strains of the bacteria and the later comprising the 
saprophytic or free-living strains found in the environment. These two were differentiated 
using various biochemical tests (Johnson & Faine, 1984; Faine & Stallman, 1982). 
Genotypic classification has now been established, though both methods of classification 
are currently in use. 
3.1.1 Serological classification 
Leptospira bacteria were initially classified into species based on serological approaches. 
This led to the simplest taxa of Leptospira being the serotype, which can also be called 
serovar. Serotypes are determined by cross-absorption with homologous antigens. If at least 
10% of the homologous titre remained in at least one of the two antisera in repeated tests, 
then serological relatedness would be established (Dikken & Kmety, 1978).  Strains that 
belonged to different serotypes but showed antigenic relatedness have been grouped into 
serogroups. Serogroups are useful for epidemiological studies as well as for interpreting 
results from the microscopic agglutination test (MAT), even though they have no place in 
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the taxonomy of the bacteria (Levett, 2015). Serological classification is therefore more 
familiar to epidemiologists and clinicians and continues to function independently from the 
genetic classification (Bharti, Nally, Ricaldi, et al., 2003; Smythe, Adler, Hartskeerl, et al., 
2013). So far, there are more than 260 pathogenic serotypes and more than 60 saprophytic 
ones identified (Adler & de la Peña Moctezuma, 2010). 
A summary of the common serogroups of L. interrogans sensu lato can be found in Table 2 
below. 
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Table 2: A summary of common serogroups of L. interrogans sensu lato along with some associated serotypes, 
adapted from Levett, (2015) 
Serogroup Serotype(s) 
Icterohaemorrhagiae Copenhageni 
Icterohaemorrhagiae 
Lai 
Grippotyphosa Grippotyphosa 
Canalzonae 
Ratnapura 
Autumnalis Autumnalis 
Bim 
Fortbragg 
Cynopteri Cynopteri 
Mini Mini 
Georgia 
Australis Australis 
Bratislava 
Lora 
Serjoe Hardjo 
Serjoe 
Panama Panama 
Mangus 
Hebdomadis Hebdomadis 
Jules 
Ballum Ballum 
Arborea 
Bataviae Bataviae 
Louisiana Louisiana 
Lanka 
Canicola Canicola 
Celledoni Celledoni 
Djasiman Djasiman 
Hurstbridge Hurstbridge 
Javanica Javanica 
Manhao Manhao 
Pomona Pomona 
Pyrogenes Pyrogenes 
Ranarum Ranarum 
Sarmin Sarmin 
Shermani Shermani 
Tarassovi Tarassovi 
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3.1.2 Genotypic classification 
Classification of leptospires based on genetic relatedness was later adopted and was based 
on DNA-DNA hybridization studies. This method has led to the identification of 20 species 
(Table 3).  
A species was defined by Brenner et al. (1999) using three criteria from taxonomic DNA 
hybridization studies: 70% or more relatedness at 55°C renaturation temperature; 5% or 
less divergence within sequences that are related; and 60% or more relatedness at 70°C 
stringent renaturation temperature.  
The previously unnamed genomospecies 1, 3, 4 and 5 were later assigned L. alstonii, L. 
vanthielii, L. terpstrae, and L. yanagawae respectively (Smythe, Adler, Hartskeerl, et al., 
2013). Both the L. interrogans and L. biflexa names remained in the genotypic 
classification, though they refer to the genetically identified species L. interrogans sensu 
stricto and L. biflexa sensu stricto (Levett, 2015). L. idonii is the latest entrant identified in 
using this classification (Saito, Villanueva, Kawamura, et al., 2013).  
Identification based on sequences of key genes has made species identification of 
leptospires possible without the need of DNA-DNA hybridization studies. The 16S rRNA 
(rrs) gene is widely used for phylogenetic classification of leptospires (Morey, Galloway, 
Bragg, et al., 2006) and has led to the bacteria being grouped into three major clusters; 
pathogenic, intermediate and saprophytic species. Other genes have also been proposed for 
this purpose as well, viz., gyrB (Slack, Symonds, Dohnt, et al., 2007), secY (Ahmed, 
Engelberts, Boer, et al., 2009), rpoB (Scola, Bui, Baranton, et al., 2006), among many 
others. 
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Table 3: All the species of Leptospira accepted so far based on molecular classification, adapted from Levett, (2015) 
16S rRNA phylogenetic cluster Species 
Pathogenic species L. alexanderi  
L. alstonii  
L. borgpetersenii  
L. interrogans  
L. kirschneri  
L. kmetyi  
L. noguchii  
L. santarosai  
L. weilii 
Intermediate species L. broomii  
L. fainei  
L. inadai  
L. licerasiae  
L. wolffi 
Free-living (saprophytic) species L. biflexa  
L. idonii  
L. meyeri  
L. terpstrae  
L. vanthielii  
L. wolbachii  
L. yanagawae 
 
 
3.2 History 
The clinical syndrome now termed leptospirosis was first described in modern history by 
Weil in 1886 (Adolf, 1886). The causative agent was later on described by Stimson (1907), 
who named the causative agent Spirocheta interrogans due to the morphological 
resemblance of the bacteria to a question mark (Figure 1). Leptospira however were first 
isolated from clinical cases by Inada et al. (1916). Rats were soon established as carriers of 
the disease, a detail that became vital in understanding leptospiral epidemiology. The 
chemical composition of water and soil was also seen as important in proliferation of the 
bacteria in the environment (Ido, Hoki, Ito, et al., 1917).  
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Figure 1: (a) Dark field and (b) Shadowed electron photomicrographs of leptospires (Adler & de la Peña Moctezuma, 
2010) 1  
A strain of this bacteria, Hond Utrecht IV, was first isolated in dogs in 1933 (Klarenbeek & 
Schuffner, 1933). The disease was first reported in cattle as “infectious yellow fever of 
cattle” in 1940 (Semskov, 1940). The disease was recognized as an infectious disease of 
most mammalian species, with the role of domestic animals considered important in the 
spread of the disease among humans. It is now well known that leptospirosis contributes 
significant economic impact in livestock productivity, especially because of abortion 
storms and decreased milk yield from sick animals (Schneider, Jancloes, Buss, et al., 2013) 
                                                                
1 Reproduced from Adler, B. & de la Peña Moctezuma, A., (2010). Leptospira and leptospirosis. Veterinary 
Microbiology, 140(3-4), pp.287–296., Copyright (2016), with permission from Elsevier  
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Certain animal hosts have been seen to be common reservoirs to some serotypes of the 
bacteria, as highlighted in Table 4 below. 
3.3 Microbiology 
Leptospires are spirochaetes with particularly coiled bodies that give them a helical 
morphology. They are approximately 0.1µm diameter and 6 - 20µm in length. They are also 
highly motile and have characteristic hooked ends (Figure 1). They have two periplasmic 
flagellae that exhibit rotational and translational movements (Goldstein & Charon, 1988; 
Levett, 2015) and pathogenic strains have a double membrane consisting of an outer and 
inner membrane (Faine, Adler, Bolin, et al., 1999). The inner membrane is closely 
associated with the peptidoglycan cell wall and is separated from the outer membrane with 
a periplasmic layer. The outer membrane consists of surface proteins (e.g. LigA, LigB and 
Loa22), transmembrane proteins, porin L1 and lipopolysaccharide. LipL32 is an important 
subsurface protein within the outer membrane as well (Fraga, Carvalho, Isaac, et al., 2015). 
The bacteria are obligate aerobes that grow optimally at 28 - 30°C and at a pH of 7.2 to 7.6. 
They are catalase and oxidase positive and grow in media enriched with long-chain fatty 
acids, ammonium salts and vitamins (Johnson & Faine, 1984). Media most commonly used 
in contemporary practice for growth of these bacteria are based on the Ellinghausen-
McCullough-Johnson-Harris (EMJH) medium initially described by (Ellinghausen & 
McCullough, 1965) and (Johnson & Harris, 1967). Leptospires are gram-negative but silver 
staining and immunostaining techniques can offer better results and can be useful for post-
mortem diagnosis using fixed or unfixed tissues (WHO, 2003). 
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3.4 Transmission  
Animal infections usually happen in areas with the common risk factors for leptospirosis, 
like moist and warm climates, as well as areas with high rodent infestation and poor 
sanitation (Ellis, 2015). The infection is maintained in the sylvatic cycle through 
transmission between rodent carriers. Animals acquire the infection from contact with 
rodent species or infected animals in the herd. The pathogens are transmitted to humans by 
direct contact with reservoir animals or through contaminated soils and water (from urine 
of infected animals). Leptospira-infected animals shed the bacteria largely through urine 
(though saliva and blood also may contribute) into the water and soil (Ko, Goarant & 
Picardeau, 2009). This process has been summarized with Figure 2 below. 
Leptospires also demonstrate preference to animal hosts, with evidence of certain serotypes 
often being isolated from these animal species as illustrated in Table 4 below. 
3.5 Pathogenesis 
The bacteria infect most animals through entry via mucous membranes of the eye or ear, 
mouth, genital tract and broken skin. The bacteria incubate for about 4-20 days, after which 
they will be present in the blood stream of the animal and persist for 7-10 days. The 
bacteria can be isolated from blood, cerebrospinal fluid (CSF) and many organs of the 
animal (liver, lungs, central nervous system, kidney, genital tract) where they are 
replicating during this leptospiremic phase. Agglutinating antibodies which are now in 
circulation at this phase are also demonstrable. This bacteremic phase usually coincides 
with the acute leptospirosis. Signs and symptoms of the acute disease vary with the host 
and the infective serotype, but many include renal damage, hemolytic disease, 
hemoglobinuria, icterus and death. Buffalo, cattle and sheep may present with agalactia. 
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Table 4: Animal reservoir hosts commonly associated with certain serotypes, adapted from Bharti et al., (2003) 
Reservoir host Serotype(s) 
Bats Cynopteri  
Wolffi  
Cattle Hardjo 
Pomona  
Dogs Canicola  
Bratislava (Ellis, 2015) 
Horses Bratislava  
Marsupials Grippotyphosa  
Mice Ballum  
Arborea  
Bim  
Pigs  Pomona 
Tarassovi 
Bratislava (Ellis, 2015) 
Kenniwicki (Ellis, 2015) 
Racoon Grippotyphosa  
Rats Icterohaemorrhagiae  
Copenhageni  
Sheep Hardjo  
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Figure 2: The transmission cycle of leptospirosis, considering the environment, rodent hosts, domestic and wild 
animals and human beings 
 
After this leptospiremic phase, the bacteria sequester in the proximal tubules of the kidney 
nephron where they multiply and get shed into the urine of the infected animal. 
Leptospiuria may persist for varying periods, depending on the species, individual animal 
and the infective serotype. The bacteria may also localize in the uterus of pregnant females 
to cause intrauterine infections which, especially late in the gestation period, may result in 
stillbirths, abortions and neonatal disease. Infertility may also arise from chronic 
colonization of the uterus and oviducts. Immune response from the host usually clears the 
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bacteria from the blood and tissues, eventually eliminating it from the host. This however 
may not be the case in renal tubules and even the vitreous humor of the eye, which are 
immune-privileged. This may lead to continued shedding of the pathogen even after the 
illness ends (Merckvetmanual.com, 2016; Ellis, 2015; Ko, Goarant & Picardeau, 2009). 
3.6 Diagnosis 
There exists a wide array of diagnostic methods for detection of the presence of leptospires 
currently in use, each with their own specificity and sensitivity. The Microscopic 
Agglutination Test (MAT) first described by (Martin & Pettit, 1918) is regarded as the gold 
standard for diagnosis of leptospirosis in humans and animals (Goris & Hartskeerl, 2005). 
The test has been modified from the original description and has high diagnostic specificity 
(WHO, 2003). It is performed by incubating patient serum with a panel of Leptospira 
serotypes. The MAT titer is obtained by testing for reactivity between the positive serotype 
and the test sera at different dilutions. Agglutination is visualized by dark-field microscopy. 
Serotypes that show reactivity with patient sera are thought to be the infective serotypes, 
even though evidence shows that cross-reactivity between serotypes is possible. Due to this 
cross-reactivity, this method may not always identify the infective serotype. Antibodies 
against the infective serotype in a patient’s serum may not be detected if the infective 
serotype is not represented in the panel of antigens used in the test used: in this case, there 
will be no MAT titre. Low MAT titers can also be found when the infectious serotype is 
not represented in the panel but agglutination with serotypes that are antigenically similar 
to the infective one happen. Therefore, the presence of low or no MAT titre does not 
exclude presence of the disease in this case (WHO, 2003). Knowledge of the epidemiology 
of leptospirosis therefore greatly aids in the choice of leptospires to include in a panel in 
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any lab, as locally circulating serotypes should necessarily be included. When local 
serotypes are unknown, serotypes representing all serogroups should be included. This 
method also relies on the use of live bacteria, a risk that other diagnostic methods may not 
pose to laboratory staff (Chirathaworn, Inwattana, Poovorawan, et al., 2014; WHO, 2003). 
MAT can detect both IgM and IgG antibodies. Standardization of the test however is not 
possible because of the many differences in the live antigens used by different labs all over 
the world (WHO, 2003). This method is also expensive and time consuming, a challenge 
that led to development of many other rapid diagnostic tests, especially when dealing with 
clinical cases which are usually time-sensitive. 
Enzyme Linked Immuno-sorbent Assays (ELISAs) are useful for detection of genus-
specific antibodies but are not recommended for serotype identification. They are relatively 
simpler to conduct than the MAT and have high sensitivity and specificity, hence their 
preference in many epidemiologic surveys (WHO, 2003). Some ELISA kits used currently 
are Panbio® Leptospira IgM ELISA (Panbio Diagnostics, Montpellier, France) for 
diagnosis in humans as well as the Linnodee Leptospira ELISA KitTM (Linnodee Animal 
Care, Ballyclare, Northern Ireland) for diagnosis in cattle. IgM antibodies have been shown 
to be detectable even after 3 years after onset of illness in humans (Ari, Guracha, Fadeel, et 
al., 2011) and perhaps may be useful in determining both acute and chronic cases in 
seroprevalence studies. 
Other serological diagnostic tests that can be used include; indirect fluorescent antibody test 
(IFAT), counter-immunoelectrophoresis (CIE), complement-fixation test (CFT), dipstick 
tests like LEPTO Dipstick and LeptoTek Lateral Flow, dried latex agglutination test 
(LeptoTek Dri-Dot), latex agglutination test (LA), indirect haemagglutination test (IHA), 
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macroscopic slide agglutination test (SAT), microcapsule agglutination test, patoc-slide 
agglutination test (PSAT) and sensitized erythrocyte lysis test (SEL) (WHO, 2003). 
Polymerase Chain Reaction test (PCR) can be used for detection of the bacteria in clinical 
samples. The test detects the presence of the bacteria through enzymatic amplification of a 
gene of choice in leptospiral DNA. Amplicons can be detected through intercalating dyes 
that associate with the amplicons and gel electrophoresis for conventional PCR, or during 
real-time PCR. Being a molecular technique, PCR can detect very minute levels of the 
bacteria and is therefore useful in diagnosis of early cases of the illness. The technique can 
also be used to detect all pathogenic leptospires when primers for conserved regions of the 
genome are used. The technique however requires valid controls, specialized skills and 
laboratory equipment in a lab. 
3.7 Treatment, prevention and control 
Treatment of acute animal leptospirosis is usually done by administration of an antibiotic 
therapy as well as clinical management of symptoms. The control of the disease has not 
changed much through the years as well. Though there exists few clinical trials to 
determine the role of various antibiotics in the treatment of leptospirosis, most will go for 
penicillin and streptomycin to treat acute illness. Treatment of herds of cattle, sheep and 
pigs may involve use of vaccination alongside the antibiotic therapy to obviate reproductive 
wastage. In chronic illness, antibiotic therapy may be used to mitigate abortion storms in 
pigs (Ellis, 2015).  
Avoidance of free-ranging of animals as a preventative measure against acquiring the 
disease is difficult since rodent reservoirs can be found in all environments and can 
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therefore transmit the illness. The most valid preventative measure therefore is vaccination 
using polyvalent inactive vaccines (Merckvetmanual.com, 2016). Vaccination has also been 
used in humans for preventative purposes as it is quite difficult to employ other measures 
like occupational hygiene (Adler & de la Peña Moctezuma, 2010). Vaccines are 
commercially available for dogs, pigs and cattle, but vaccination efforts have shown to be 
only partly effective due to the serotype-limited immunity elicited by the vaccine used, as 
well as the possibility of local serotypes being present in the area targeted by the 
vaccination program that are not in the vaccine supplied. The success of vaccination efforts 
therefore requires knowledge of the epidemiology of the disease before execution (Adler & 
de la Peña Moctezuma, 2010). Vaccines have also been shown to confer cross-protection 
against different serotypes of the bacteria in various experimental studies (Sonrier, Branger, 
Michel, et al., 2000; Rosario, Arencibia, Suarez, et al., 2012; Dib, Gonçales, de Morais, et 
al., 2014).  
Human prevention efforts, as with animal ones, also depend on understanding the 
epidemiology and the local risk factors of the disease. Human leptospirosis is strongly 
linked to poverty and efforts that prevent contact of rodents with humans in their living 
spaces greatly reduce the risk of transmission of the disease. Flood-control projects that 
prevent flooding of residential areas also prevent outbreaks of the disease. The use of 
personal protective equipment (PPE) for workers at high-risk can also prevent infection by 
offering a physical barrier to points of entry of the bacteria. Avoidance of water sports as 
well as walking bare foot in endemic areas can also reduce risk of infection. Diagnosis and 
treatment as well as immunization of agricultural or companion animals also plays a key 
role in prevention of the disease in humans (Haake & Levett, 2015)  
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3.8 The zoonotic potential of leptospirosis 
Humans are considered dead-end hosts and there is no documented human-to-human 
transmission. Humans also do not shed enough of these pathogens to be important reservoir 
hosts (Ko, Goarant & Picardeau, 2009). Leptospirosis has been considered an occupational 
hazard, especially for people who work with water and sewage systems (miners, sewer 
workers and fish farmers) (Waitkins, 1986) and those that are exposed to animals and their 
bodily fluids of animals. Veterinary staff, dairy workers and livestock and pig farmers, 
butchers, and rodent control workers are at risk of occupational exposure 
(Merckvetmanual.com, 2016; Vijayachari, Sugunan & Shriram, 2008). There also exists 
exposure from certain recreational activities, including water sports (Vijayachari, Sugunan 
& Shriram, 2008). These may include swimming in lakes, hunting, canoeing, biking 
through infected water, rafting, hiking, caving, trail biking, kayaking, hunting and fishing 
(Pavli & Maltezou, 2008; Antony, 1996). This is because of the associated risk factors that 
come with these activities which include but not limited to; immersion in water, walking 
barefoot, contact with floodwater, and drinking river water, especially when having skin 
wounds. 
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4. Materials and Methods 
4.1 Study Area 
The study was done in Bura and Hola irrigation schemes of Tana River County as well as 
Ijara and Sangailu divisions of Ijara district in Garissa County (Figure 3) and (Figure4).  
Tana River County is located in the former Coast Province of Kenya located between 
coordinates 1°30′ S, 40°0′E and 1.5° S, 40° E (Koech, Kinuthia, Karuku, et al., 2016). The 
county is 38, 436.9 sq. km. (KenInvest, 2016) and is named after the Tana River which 
supplies the surrounding area with water. The county is composed of three constituencies; 
Garsen, Galole and Bura (Kenya Open Data Portal, 2016). The population according to the 
2009 population and housing census of Kenya was 240,075 people (Kenya National Bureau 
of Statistics, 2010) and more than 70% of people here live below the absolute poverty line 
(Koech, Kinuthia, Karuku, et al., 2016). The area is generally hot and dry, receiving low 
and erratic conventional rainfall of a bimodal pattern and a long-term annual average of 220 
to 500mm of rainfall. Rainy seasons are usually from April to June and November to 
December (Koech, Kinuthia, Karuku, et al., 2016). Farming and pastoralism are the main 
economic activities in this semi-arid area. The area has seen development of irrigation 
schemes, the biggest of these having been set up by the Kenyan government. The biggest 
irrigation schemes in this area are the Hola Irrigation Scheme, Bura Irrigation Scheme and 
the Tana Delta Irrigation Project and are used for maize and rice production (Tana River 
County, 2016).  
Ijara is a sampling site located in Garissa County of Kenya. Garissa County is located in the 
former North Eastern province of Kenya. In the last census it had a population of 623,060 
people (Kenya National Bureau of Statistics, 2010). The county has 6 constituencies; Fafi, 
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Garissa Township, Lagdera, Dadaab, Ijara and Balambala. The county is regarded as arid 
and the main economic activity is pastoralism. The Tana River is a major source of water 
for this dry area. The climate of the county is semi-arid, with temperatures ranging from 
21°C to 39°C and bimodal rainfalls averaging 250 to 300mm annually. Rainy season is 
usually from March to May and September to October. The county has a large number of 
nomadic pastoralists who live in some of the harshest climates on earth (Gore-Langton, 
Mungai, Alenwi, et al., 2015) 
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Figure 3: A map of Kenya with counties involved in the study highlighted 
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Figure 4: Tana River and Garissa Counties with towns involved in the study highlighted 
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4.2 Study design 
The work was designed as a pilot study that could check for the presence of the disease in 
rodent carriers. This would inform fuller observational studies in estimating prevalence for 
sample size calculations. It would also show the need for further studies that would 
elucidate leptospirosis in the study area. Execution of the project would demonstrate the 
time, feasibility, methodology and adverse events in future studies. The study was done on 
a small-scale and meant to demonstrate the presence of the pathogen in areas sampled by a 
larger project; the Dynamic Drivers of Disease in Africa: Ecosystems, livestock/wildlife, 
health and wellbeing: RVF case study in Kenya project (REF. NE/J001422/1). Ethical 
approval for this project was done by the Ethics and Scientific Review Committee (ESRC) 
of the Africa Medical and Research Foundation (AMREF) (REF: AMREF-ESRC 
P65/2013). 
No sample size was calculated for this pilot study before animal sampling was done. 
4.3 Setting of rodent traps 
Biological samples used in this study originated from rodents collected during the months 
of October and November, 2013 as well as March 2014. Collection of rodents had been 
done in and around human dwellings as well as in the surrounding environment, using the 
method briefly described here. Sherman rodent traps (H. B. Sherman Traps Inc., 
Tallahassee, FL) from the National Museums of Kenya (NMK) were set in Ijara district as 
well as Bura sub-county and Hola town.  
Traps in Bura and Hola towns were set in October, 2013 and March 2014. These were close 
to the areas that had animals tested as part of the field work for the DDDAC project. The 
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traps were placed near human settlements, in wild shrub land forests and on irrigation 
farms. Traps were placed close to irrigation canals, near holes, on trees, and putative rat 
trails. In human settlements, traps were placed in kitchens and on top of shelves where food 
is stored as well as in living places. In Hola town, traps were laid in Matanya village and 
the forest surrounding the National Youth Service (NYS) garage. 
In Bura town, the traps were set in temporary structures and human settlements within the 
Bura Irrigation Scheme, farms and bushes as well as in the Bura Country Club. 
In Ijara, traps were set in Sangailu and Ijara towns and were set strategically inside and 
outside houses, bushes, inside and outside shops as well as in human settlement areas. 
Traps were set in December 2013 and March 2014. 
A total of 119 samples (Table 5) had been collected from the field.  
Table 5: Distribution of rodents collected with the towns in the study sites 
Species collected Bura Hola Ijara Sangailu Grand Total 
Acomys wilsoni 0 7 1 0 8 
Arvicanthis niloticus 1 0 0 0 1 
Gerbilluscus robustus  0 0 1 0 1 
Mastomys natalensis 18 3 1 11 33 
Mus musculus 26 27 11 10 74 
Rattus rattus 0 2 0 0 2 
Grand Total 45 39 14 21 119 
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4.4 Sample collection 
Collected rodents had been euthanized humanely using an intraperitoneal injection of 
Ketaminol 50mg/ml. The rodent species were identified by mammologists from the NMK. 
Blood samples were obtained where possible, as well as internal organs, and put in 
cryovials. Urine and the urinary bladder were also obtained where possible. Rodent 
morphometric data was also recorded and included weight, total length, tail length, hind 
foot length and ear length. The sex and estimate age (whether adult, juvenile or sub-adult) 
of the rodents were also noted as well as autopsy comments.  
All samples collected were stored in cryovials that have unique barcode identifiers. They 
were put in dry ice and transported to the International Livestock Research Institute (ILRI) 
headquarters in Nairobi, Kenya where they were archived in liquid nitrogen in the Azizi 
Biorepository before analysis in this study.  
In total, 69 rodent samples had blood and kidney tissue available for PCR tests for this 
study. DNA for two of these rodents got degraded and therefore did not yield results. The 
total number of rodents used for the analysis therefore was 67. 
4.5 Sample analysis 
4.5.1 DNA extraction 
Extraction was done using automated DNA extraction as well as manual methods. The 
automated extraction was carried out on all blood samples using the MagNA Pure LC 
machine (Roche Diagnostics, Risch-Rotkreuz, Switzerland). The kit used was the high 
performance MagNA Pure Total Nucleic Acid isolation kit (Roche Diagnostics, Risch-
Rotkreuz, Switzerland, Cat. No. 03038505001). Kidney tissue from the rodents was used in 
37 
 
the extractions. These underwent manual extraction using the DNeasy® blood and tissue 
kit (Qiagen, Hilden, Germany). Manufacturer’s instructions guided the extraction in both 
protocols. Extracted nucleic acids were stored at -80°C until use. 
4.5.1.1 MagNA Pure LC 
The MagNA Pure LC can extract 32 samples at a go. The steps used in this procedure were 
as follows: 
i. The MagNA Pure 3.0 software was initialized.  
ii. Under sampling order, the identifiers for the samples and controls were keyed in. 
The extraction protocol “Total NA HS200.bk” was used. No post-elution settings 
were set (we selected none). The MagNA Pure LC kit lot number was also keyed in. 
The sample volume was set at 200µl, elution volume at 50µl and dilution volume at 
0µl as these were thought to be comparable. 
iii. Under the stage setup menu, the reagent tubs for wash buffers I, II and III, 
lysis/binding buffer, proteinase K, magnetic glass particles (MGP) and elution 
buffers were set in their respective places in the machine. The volumes specified by 
the machine were also added to the tubs – these volumes are automatically 
calculated by the MagNA 3.0 software depending on the number of samples being 
analyzed. Tip trays were also filled with the appropriated tips. 
iv. The extraction was initialized and was performed automatically for the samples 
chosen. 
v. After extraction, the DNA eluate was held on the cool block 
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Extracted DNA was quantified and transferred into 1.5ml Eppendorf tubes for safe storage 
at -80°C. Tubes were duly labelled using a permanent marker with the sample identification 
number. 
4.5.1.2 Qiagen DNeasy® manual extraction method 
DNA extraction using the DNeasy® blood and tissue kit from Qiagen was done as per the 
manufacturer’s instructions (Qiagen, 2011). A negative extraction control (NEC) was 
included in every batch of extractions performed. This comprised of extraction reagents 
only and no sample. 
The procedure was as follows: 
1. Lysis was done for blood and tissue samples as follows. 
i. The whole kidney was used in this extraction. Tissues were cut into small pieces 
using sterile surgical blades on a cutting surface (changed between different 
samples) and placed into 1.5ml Eppendorf tubes. 180µl of ATL buffer was added 
and 20µl proteinase K after this. This was mixed by vortexing and incubated at 
56°C until complete lysis happened; occasional vortexing was done during the 
incubation 
ii. For the blood samples, 20µl proteinase K was put into a 1.5ml Eppendorf tube and 5 
-10µl of the blood was put, depending on the available volume. The volume was 
adjusted to 220µl using Phosphate Buffered Saline (PBS). 200µl of AL buffer was 
added, mixing done by vortexing and incubation of the blood sample was done at 
56°C for 10 min 
2. 200µl of absolute ethanol was added to every tube and mixing was done by vortexing 
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3. The mixture was transferred into the DNeasy Mini spin columns placed in 2ml 
collection tubes supplied with the kit. Centrifugation was done at 1000 rpm for 1 min 
and the collection tubes with the flow-through liquid were discarded. 
4. The spin column was placed into a new collection tube and 500µl of AW1 buffer was 
added. Centrifugation at 1000rpm for 1 min was done. The collection tubes with the 
flow-through were discarded 
5. The spin column was placed into new collection tubes and 500µl of AW2 buffer was 
added. Centrifugation was done at 14000 rpm for 3 min. The flow-through liquid in the 
collection tube was discarded. 
6. The spin column was put in a new 1.5ml Eppendorf tubes and elution was achieved by 
adding 200µl of AE buffer into the centre of the spin column membrane. Incubation for 
1 min at room temperature was done after which centrifugation for 1 min at 1000 rpm 
was done to complete the extraction 
Tubes having the extracted DNA were well labelled and aliquoted into working aliquots 
and stock aliquots. Working aliquots underwent the dilution step and the stock aliquots 
were stored at -80°C. 
Concentrations and purity of the working aliquots were determined using the NanoDrop™ 
1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). Concentrations 
above 100ng/µl were diluted down to 100ng/µl so as to be suitable for PCR. No DNA 
eluates were set aside from the PCR because of lack of DNA. The lowest concentration 
obtained was 0.62ng/µl. DNA purity was determined using the A260/A280 and A260/A230 
ratios. Extracted DNA was visualized on an agarose gel as shown in Figure 5 below. 
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Figure 5: Gel photo of genomic DNA extracted using the DNeasy® protocol, with lanes 1 and 2 showing DNA from 
kidney tissue and lane 3 showing the negative extraction control 
 
4.5.2 Polymerase chain reaction (PCR) 
A conventional (endpoint) PCR test to detect leptospiral DNA was done on the nucleic 
acids isolated from the rodent blood and tissue samples. The thermocycling conditions are 
as Table 6 illustrates. Annealing temperature for the primers was determined using the 
Eppendorf MasterCycler® Nexus Gradient thermocycler (Thermo Fisher Scientific, Waltham, 
MA, USA). The GeneAmp® PCR system 9700 Thermocyler (Thermo Fisher Scientific, 
Waltham, MA, USA) was used for the tests after optimization of the PCR conditions was 
done.  
  
     1      2   NEC 
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Table 6: Conditions optimal for amplification of leptospiral DNA using G1/G2 primers 
Step Temperature in 
degrees Celsius (°C) 
Time in minutes 
(min) 
 
Initial Denaturation 95 3  
Denaturation  95 0.5 
40 cycles Annealing 55 1 
Extension 72 1 
Final Extension 72 10  
Hold 10 ∞  
 
DreamTaq Green PCR master mix and Nuclease Free Water provided in the kit from 
ThermoFischer Scientific (Thermo Fisher Scientific, Waltham, MA, USA; Cat. No. K1081) were 
used. G1/G2 primers (Inqaba Biotec East Africa Ltd.) that detect L. interrogans sensu lato 
with the exception of L. kirschneri were used.  These primers were first described by 
(Gravekamp et al., 1993) and target the sec-Y gene that codes for the translocase SecY 
protein. A lack of positive control that could be used for B64-I/B64-II primers that target 
the flagellin gene of L. kirschneri meant that we could not detect the group, even though 
many studies have demonstrated the species in rodents (Mayer-Scholl et al., 2014; Halliday 
et al., 2013). The G1/G2 and B64I/B64II primers are usually used as a set for the detection 
of pathogenic leptospires (Gravekamp et al., 1993). 
A gradient PCR was performed to determine the best annealing temperature for the PCR 
reaction (Figure 6). An annealing temperature of 55°C was chosen because it could detect 
weakly positive samples, though it also caused non-specific amplifications in some samples 
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(Figure 7, Lane 2). It was therefore decided that DNA purification of the bands of interests 
was to follow to do away with all non-specific amplifications. 
Controls used in every PCR run included a non-template control (NTC) and a positive 
amplification control (PAC). The non-template control included PCR reagents only and 
nuclease-free water was added in the place of DNA template.  The positive amplification 
control used was a DNA construct with part of the secY gene. 
 
Table 7: Master mix recipe used for G1/G2 reactions 
PCR reagent Stock 
concentration 
Working 
concentration 
1 reaction 
(µl) 
DreamTaq Green PCR Mastermix  2x 1x 12.5 
Nuclease Free Water (NFW)   8.5 
Forward primer (10µM) 100µM 10µM 1.5 
Reverse primer (10µM) 100µM 10µM 1.5 
DNA template   1 
Reaction Volume   25 
 
A summary of the master mix recipe is highlighted in Table 7 above. 
A summary of the primer and positive control construct sequences used can be found in 
Table 8. 
PCR products were stored at -20°C until further use. 
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Table 8: Sequences of primers used to identify pathogenic Leptospira species (except L. kirschneri) as well as positive 
control construct used 
 
 
Name Sequence Length and position 
in target gene 
G1 
 
5' CTGAATCGCTGTATAAAAGT 3' 
 
276-295=20 bp 
 
G2 
 
 
 
5' GGAAAACAAATGGTCGGAAG 3'  
 
11-30=20 bp 
 
Leptospira spp. synthetic 
construct used as a 
positive amplification 
control (PAC). Binding 
sites are underlined. 
5'TCTGCAGTACGGAAAACAAATGGTCG
GAAGAAAAATGGTTCAGGCCAAGAGT
CAATCTATTCCTTTCAAAGTAAACGGC
GCGAACGTGATGCCGATCATTTTTGCT
TCGTCTTTGATTTTATTTCCTCAGACGA
TTATTCAATGGTTATCTAATAGTAGTCA
AGAATGGGCTGGATGGGCAGTGATTAT
GGATTTTTTTAATCCATTCTCTCAGATT
TGGTATCATGCGTTATTTTATTTCGTAA
TTTATACCGCTTTAATTGTATTCTTTGC
TTACTTTTATACAGCGATTCAGTTTAAT
CCTGCCCGGGTTTGGAATCTCCACCCC
CGAACAAGCAAGTCAAATTGCCGGGTA
TGCGGACGGAATCATCATCGGATCTGC
CATCCAAAGGGTCATCGAAGAGAATG
GGCAAGACGCTTCCAAAGCAAAAAAT
GTTTTGGCGGACTACATAACAAAGATT
CGGGCATCAATTTCCTAAATTTTTTTCC
GAAATCACTCAAAAACATTTGAGTCTC
TTTAAAAAATCCGAGAGAATGGTCGGA
AATTCCTTAACGAATAAAGAGGCTCTA
TGTCCCCCGGGAAATGGACTGCGGATG
CAGCTGCTAAAGGTCGTTTAATCAATG
TTACTGAACTAACAACTGCAGGTAAAT
CAGGAGCGGCTTTAGTTGCTTTTAGAT
CGGCAGCTTTGGCTGGTGCTGCTACTT
GTGCAAAAGATATCTTATCCAAGGAAA
GTGAAGAGGCACAGCGCATTGCTTTCT
CTCTACAT 3' 
 
767bp 
Product = 285bp 
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4.5.3. Agarose Gel Electrophoresis 
PCR products were run on 2% agarose gels and run for 30 minutes at 100Volts. 0.5X TAE 
buffer (procedure in Appendix 1) was used to prepare the gel as well as the running buffer. 
GelRed™ nucleic acid gel stain was used for illumination under ultraviolet light.  
No loading dye was used as the master mix used is pre-laced with loading dye. 5µl of the 
PCR product was loaded to the gel and 3µl of O'GeneRuler™ 100bp ready-to-use DNA 
Ladder (ThermoFischer Scientific, Waltham, MA, USA; Cat No. SM1143) were used for the 
electrophoresis. 
Gel photos were taken using ultraviolet (UV) light trans-illumination and gel photos 
labelled and saved. Bands of interest were at 285bp. 
        
 
 
 
 
 
 
 
 
M     1      2       3       4      5       6      7       8      9      10    11    12    M 
50.0 °C 64.0 °C 57.0 °C 
Figure 6: Gradient PCR to determine best annealing temperature of G1/G2 primers using 20ng/µl of the positive 
control. The key used is 1. 50.0, 2. 50.4, 3. 51.2, 4. 52.5, 5. 54.4, 6. 56.1, 7. 57.9, 8. 59.6, 9. 61.5, 10. 62.8, 11. 63.6, 
12. 64.0 and M for Molecular Weight ladder (100bp) 
 
100bp 
500 bp 
 300 bp 
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Figure 7: Gel electrophoresis of PCR products, with lane 1 showing a positive sample, lane 2 showing a band of non-
interest as it is not in the required region of 285bp. Lanes 3 and 4 showing the non-template control (NTC) and 
positive amplification control (PAC) respectively. 
 
4.5.4 Gel purification 
Some samples exhibited multiple bands at the chosen annealing temperature of 55°C. 
Therefore, for a subset of samples that had the band of interest (285bp), the area containing 
the band was extracted from the gel and DNA purification. The commercial kit used for this 
step was the Wizard® SV Gel and PCR Clean-Up System (Promega Corporation, Madison, 
WI, USA; Cat. No. A9281/2/5). Purified DNA product in some samples was run on gel to 
confirm presence of band of interest before sending for sequencing (Figure 8) 
The process was as follows: 
1. Microcentrifuge tubes were labelled with the sample IDs and weighed. 
2. Bands of interest on the agarose gel were excised on a UV illuminator using 
a clean blade and placed into the tubes. 
      M     1     2     3     4     
500 bp 
200 bp 
300 bp 
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3. The tubes were weighed with the gel slice in them. The weight of the slice 
was determined. The gel slice was dissolved by adding 10µl of membrane 
binding solution per 10mg of the gel slice, vortexing and incubating at 55°C 
until the gel was completely dissolved. 
4. SV minicolumns were labelled and fitted into the collection tubes provided. 
5. The dissolved gel mixture was transferred into the minicolumn assembly 
and incubated at room temperature for 1 minute. 
6. The mixture was centrifuged at 16000 rcf for 1 min. The flow-through was 
discarded and the minicolumn inserted into a fresh collection tube. 
7. 700µl of reconstituted membrane wash solution was added and the tubes 
centrifuged at 16000 rcf for 1 min. The flow-through was discarded and 
columns placed in fresh collection tubes as before. 
8. This wash step in Step 7 was repeated with 500µl of the membrane wash 
solution and centrifugation done at 16000 rcf for 5 minutes. 
9. The collection tubes were emptied and centrifuged again for 1 min at 16000 
rcf with the lid of the microcentrifuge open to allow for evaporation of 
residual ethanol. 
10. The minicolumns were transferred into clean and labelled 1ml 
microcentrifuge tubes in readiness for elution. 50µl of nuclease-free water 
was added and incubation done for 1 minute at room temperature. The 
columns were then centrifuged at 16000 rcf for 1 minute. The minicolumns 
were discarded and eluted DNA stored at 4°C in readiness for sequencing. 
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4.5.5 Sanger sequencing and phylogeny 
Some positive samples from both the irrigated and pastoral areas were sent to Macrogen 
Inc. for Sanger sequencing to ascertain that the targeted loci were being amplified by the 
PCR reaction. Consensus sequences (contigs) were developed from the forward and reverse 
sequences of the positive samples sent for sequencing using CLC Main Workbench 
software package version 6 (Qiagen, Aarhus, Denmark). 
The contigs were subjected to a search on the Basic Local Alignment Search Tool for 
nucleotides searched (BLASTn) suite to check for similarities with other DNA sequences 
(NCBI, 2016). 
Construction of a phylogenetic tree (Figure 12) was done using the Molecular Evolutionary 
Genetics Analysis software version 6.0 (MEGA6) (Tamura, Stecher, Peterson, et al., 2013) 
to check for evolutionary relatedness based on the secY gene. This gene has been used for 
M   1   NTC    M 
 200 bp 
 300 bp 
 Figure 8: PCR positive kidney sample (Lane 1) after gel purification of band of interest at 285bp. Lane 2 
is the non-template control used in the PCR reaction. Lane M is the molecular weight ladder 
(O’GeneRuler 1kb Plus DNA ladder, ThermoFischer Scientific, Walham, MA, USA, Cat. No. SM1343 
M    1 
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phylogenetic classification and has shown to be sufficiently discriminatory (Ahmed, 
Engelberts, Boer, et al., 2009; Halliday, Knobel, Allan, et al., 2013).  The neighbor-joining 
method (Saitou N, 1987) was used to generate the tree and measures of support for each 
node (given in percentage) were generated using bootstrapping tests (Felsenstein, 1985) of 
1000 replicates and was stated in beside each node. The tree is drawn to scale, with branch 
lengths in the same units as those of the evolutionary distances used to infer the 
phylogenetic tree. The evolutionary distances were determined by using the maximum 
composite likelihood method (Tamura, Nei & Kumar, 2004). 
 
4.6 Data analysis 
Data was put in MS Excel platform to create a master-list containing the rodent ID, 
sampling details (town, coordinates, dates, species and sample IDs), rodent morphometric 
data and results from these analyses. Positive rodents were determined if either blood or 
kidneys or both showed positive PCR results. Distribution of the results with rodent 
species, town of collection, sex and estimated age were derived using MS Excel (MS Office 
suite 2007, Microsoft Corporation, Redmond, WA, USA). Prevalence data was determined 
using PCR results.  
The Fisher’s exact test was used to test the null hypothesis that there is independent 
association between PCR results and the sampling sites, rodent species and estimated age of 
the rodents. This was done using STATA version 14 (StataCorp LP, Texas, USA). The 
Fisher’s exact test was chosen because of the small sample size used in this study. An Odds 
Ratio (OR) was also calculated using the same software to demonstrate the likelihood that 
rodents from pastoral areas had in carrying the bacteria than those from the irrigated area. 
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5. Results 
Kidney and blood samples from 67 rodents were analyzed using the PCR test.  
Results obtained from the analyses are as follows: 
5.1 PCR test results 
PCR tests from 67 rodents were analyzed. Positive results were obtained from 28 rodents 
(41.8% prevalence, 95% CI=29.8% - 54.5%) and the remaining 39 were negative results. 
Results were distributed with the species as represented in Table 9 below. 
Prevalence figures were: 16% (4/25) (95% CI 4.54 to 36.08) in Bura; 42% (8/19) (95% CI 
20.25 to 66.50) in Hola; 82% (9/11) (95% CI 48.22 to 97.72) in Ijara and 58% (7/12) 
(95% CI 27.67 to 84.83) in Sangailu. This is summarized in Figure 9 below.  
Table 9: PCR results with the species of rodents collected 
Species Negative Positives Total count 
 n % n %  
Acomys wilsoni 0 0.0 1 100.0 1 
Gerbilluscus robustus 0 0.0 1 100.0 1 
Mastomys natalensis 12 57.1 9 42.9 21 
Mus musculus 27 64.3 15 35.7 42 
Rattus rattus 0 0.0 2 100.0 2 
Total 39 58.2 28 41.8 67 
 
Out of the rodents tested, 44% (16/36) of the females and 39% (12/31) of the males were 
PCR positive (Figure 10). The prevalence dependent on the age of rodents was as follows; 
38.2% (21/55) among adult rodents, 50% (3/6) among sub-adults, 75% (3/4) among 
juveniles and 50% (1/2) in rodents where age was not recorded. Results of prevalence 
distribution with age are summarized in Figure 11 below. 
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Figure 9: A stacked bar chart showing distribution of PCR results with the sampling sites 
 
 
Figure 10: A stacked bar chart showing distribution of PCR results with sex of the rodents collected 
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Figure 11: Distribution of prevalence with the estimate age of rodents collected 
 
5.1.1 Hypothesis testing of PCR data with variables 
The Fisher’s exact test was performed on the town of sampling, rodent species and 
estimated rodent age. 
Bura, Hola, Ijara and Sangailu were used in the Fisher’s exact test and results are shown in 
Table 10 below. Since p<0.005, it was determined that sampling town does have an effect 
on the prevalence of leptospirosis among the rodents. 
Ijara and Sangailu were grouped as pastoral areas, whereas Bura and Hola were grouped as 
irrigated areas, to determine the influence the sampling area more precisely. The test was 
performed and it was found that the pastoral areas had significantly higher prevalence 
(p=0.002) as shown in Table 11 below. Since p<0.005, the null hypothesis was rejected. An 
odds ratio was also calculated on the pastoral and irrigated areas and OR=6.095 (CI 95% 
2.011-18.470) was obtained. 
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Table 10: Leptospira prevalence in different areas 
Town 
Total results  
Positive Negative Total 
Bura 4 21 25 
16.00% 84.00% 100.00% 
Hola 8 11 19 
42.11% 57.89% 100.00% 
Ijara 9 2 11 
81.82% 18.18% 100.00% 
Sangailu 7 5 12 
58.33% 41.67% 100.00% 
Total 28 39 67 
41.79% 58.21 100.00% 
Fisher’s exact = 0.001 
Table 11: Leptospira prevalence in areas sampled, with irrigated areas (Bura and Hola) and pastoral areas (Ijara and 
Sangailu).  
Group (town) 
PCR results Total 
Positive Negative 
Irrigated 12 32 44 
27.27% 72.73% 100.00% 
Pastoral 16 7 23 
69.57% 30.43% 100.00% 
Total 28 39 67 
41.79% 58.21% 100.00% 
Fisher’s exact = 0.002 
 
The test was also done with all the species as well as the two species with the most 
numbers in this study. When all species were compared, p=0.125 was obtained. 
Comparison with the most populace species, Mastomys natalensis and Mus musculus, 
p=0.595 was obtained. Since in both tests, p>0.005, we could not demonstrate that species 
is associated with the presence of the bacteria.  
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The Fisher’s exact test performed on all ages as well as grouped ages, adults and non-adults 
(sub-adults and juveniles combined) is as represented in Table 12 and Table 13 below. 
Since p>0.05 in both, it seems that the estimate age doesn’t have any influence on a 
rodent’s ability to carry leptospiral bacteria. 
Table 12: Fisher's exact test used on the estimated age 
Estimated age PCR results Total  
Positive Negative 
Adult 21 34 55 
38.18% 61.82% 100.00% 
Juvenile 3 1 4 
75.00% 25.00% 100.00% 
Sub-adult 3 3 6 
50.00% 50.00% 100.00% 
Total  27 38 65 
41.54% 58.46% 100.00% 
Fisher’s exact = 0.297 
 
Table 13: Fisher's exact test on age groups 
Age groups PCR results Total 
Positive Negative 
Adults 21 34 55 
38.18% 61.82% 100.00% 
Non-adults (juvenile 
and sub-adults) 
6 4 10 
60.00% 40.00% 100.00% 
Total 27 38 65 
41.54% 58.46% 100.00% 
Fisher’s exact = 0.297 
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5.2 Sequencing results 
Results from the BLASTn searches confirmed the contigs generated were leptospiral secY 
genes. 25 partial sequences of the secY gene from different leptospiral species were chosen 
and aligned using MEGA6 with the sequences from samples in this study. Phylogenetic 
analysis revealed that all 6 positives chosen for sequencing were L. interrogans as they 
clustered in this group. It was also observed that common leptospiral species clustered 
together. This is shown in Figure 12 below. Accession numbers were used as labels on the 
phylogenetic tree and descriptions of their representative sequences are shown in Table 14 
below. 
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Figure 12: Phylogenetic tree of partial sequences of the secY gene of some positive rodent samples and 25 reference 
strains representative of various leptospiral species. The tree was drawn to scale. The length of branches is 
representative of evolutionary distances.  Each node is supported by a probability next to it. 
 
 Sample TID000497
 Sample TID001048
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56 
 
Table 14: Accession numbers used in construction of phylogenetic tree 
Accession 
number 
Description 
KU216751.1 Leptospira interrogans serovar Hardjo-prajitno strain OMS protein translocase 
SecY (secY) gene partial cds 
KU216750.1 Leptospira interrogans serovar Hardjo-prajitno strain Bolivia protein 
translocase SecY (secY) gene partial cds 
CP013147.1 Leptospira interrogans serovar Hardjo-prajitno strain Hardjoprajitno 
chromosome 1 sequence 
CP012603.1 Leptospira interrogans serovar Hardjo str. Norma chromosome I complete 
sequence 
EU358012.1 Leptospira interrogans serovar Lai SecY (secY) gene partial cds 
KP862627.1 Leptospira noguchii isolate 2013 U73 preprotein translocase (secY) gene partial 
cds. 
EU358044.1 Leptospira kirschneri serovar Kunming strain K 5 SecY (secY) gene partial 
cds. 
EU357963.1 Leptospira kirschneri serovar Kamituga SecY (secY) gene partial cds. 
KM066009.1 Leptospira kirschneri strain 12-494 SecY (secY) gene partial cds. 
JN683942.1 Leptospira kirschneri strain 201001687 SecY (secY) gene partial cds. 
EU358001.1 Leptospira kirschneri serovar Ndambari SecY (secY) gene partial cds. 
EMJ95431.1 Leptospira alstonii serovar Sichuan str. 79601 preprotein translocase SecY 
subunit 
EQA80031.1 Leptospira alstonii serovar Pingchang str. 80-412 preprotein translocase SecY 
subunit 
EQA62139.1 Leptospira alexanderi serovar Manhao 3 str. L 60 preprotein translocase SecY 
subunit 
ACB05546.1 Leptospira alexanderi serovar Mengla partial preprotein translocase subunit 
SecY 
ACB05547.1 Leptospira alexanderi serovar Manzhuang partial preprotein translocase subunit 
SecY 
JN683944.1 Leptospira borgpetersenii strain 201002429 SecY (secY) gene partial cds. 
JN683935.1 Leptospira borgpetersenii strain 200901118 SecY (secY) gene partial cds. 
EQA54330.1 Leptospira kmetyi serovar Malaysia str. Bejo-Iso9 preprotein translocase SecY 
subunit 
KP862633.1 Leptospira santarosai isolate 2013 U160 preprotein translocase (secY) gene 
partial cds. 
KP862632.1 Leptospira santarosai isolate 2013 U152 preprotein translocase (secY) gene 
partial cds. 
EU357958.1 Leptospira santarosai serovar Balboa strain 735 U SecY (secY) gene partial 
cds. 
DQ882861.1 Leptospira noguchii serovar Panama SecY (secY) gene partial cds. 
EMY61368.1 Leptospira terpstrae serovar Hualin str. LT 11-33 ATCC 700639 preprotein 
translocase SecY subunit 
ABZ94397.1 Leptospira biflexa serovar Patoc strain apos Patoc 1 (Ames) apos Preprotein 
translocase SecY subunit 
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6. Conclusion  
6.1 Discussion  
There exist few studies that explore prevalence of leptospires in rodent carriers in North-
Eastern Kenya, which is an ASAL and rural area of Kenya. A recent study of Leptospira in 
rodents in Kibera slum informed about the disease in urban settings of Kenya (Halliday, 
Knobel, Allan, et al., 2013). Other major rodent studies of leptospirosis in the country date 
back to the sixties (Ball, 1966). This study is one of the few that demonstrated pathogenic 
leptospires in rodents in rural Kenya and, by extension, risk that it poses in these poor and 
marginalized communities. 
Phylogenetic analysis showed that the sequences clustered in the L. interrogans group. The 
analysis also showed clustering of all sequences that were of the same species. Different 
species remained distinct from each other as well. The saprophytic species, Leptospira 
terpstrae and Leptospira biflexa, also clustered together and showed greater evolutionary 
distances from the rest of the species in the tree (these were pathogenic and intermediate 
species). This corroborates the utility of the secY gene in phylogenetic classification due to 
its ability to greatly discriminate Leptospira spp. This study therefore adds to the growing 
use of the gene in determination of leptospiral species in epidemiological studies. 
Determination of serogroups was not included in this study due to lack of funds. This 
however falls in areas of future exploration as it will aid in many control efforts for the 
disease. 
Many studies done in urban settings have identified rats as posing great risk of transmission 
of human leptospirosis (Sarkar, Nascimento, Barbosa, et al., 2002; Faria, Calderwood, 
Athanazio, et al., 2008; Piedad, Londoño, Quiroz, et al., 2009). Mice have also been shown 
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to pose disproportionate risk of human leptospirosis compared to other species in urban 
settings (Halliday, Knobel, Allan, et al., 2013; Vanasco, Sequeira, Sequeira, et al., 2003). 
This study however didn’t show any association of the rodent species and age with the 
prevalence of the bacteria. The use of Sherman traps which have higher successes with 
trapping smaller and younger rodents may have left out larger rodents in this study, which 
have been shown to be more prevalent in carrying the bacteria than their smaller 
counterparts (Vanasco, Sequeira, Sequeira, et al., 2003; Halliday, Knobel, Allan, et al., 
2013).  
Rodent sightings have also been frequently reported among urban populations with high 
leptospirosis (Ko, Galvão Reis, Ribeiro Dourado, et al., 1999; Halliday, Knobel, Allan, et 
al., 2013). One of the inspirations of this study was the frequency of respondents to have 
sighted rodents during field work for the DDDAC project field work. The rodent 
population in the irrigated areas have also been noted by the DDDAC project to have 
increased, perhaps because of clearing of bushes as well as increased food in the farms as 
irrigation practices continue (Ontiri, Bett, Lindahl, et al., 2014). While the risk posed by 
rodent sightings need case-control studies for better understanding, it is a recurring theme 
in areas with high leptospirosis prevalence. Though there are many channels of 
transmission of the bacteria to human and animal populations, transmission through rodents 
is effective because of the nature of the carriers – very abundant and diverse, widely 
distributed populations, having close contact with humans and their animals as well as 
interaction with wildlife (Meerburg, Singleton & Kijlstra, 2009).  
This study shows that land use may have an effect in the prevalence of Leptospira in rodent 
carriers. Rodents collected from the pastoral regions (Ijara and Sangailu) had six times the 
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odds of carrying the bacteria than those from the irrigated regions (Bura and Hola). This 
could be attributed to the scarce water sources in the areas which allow for sharing among 
human populations, domestic animals, wild life and rodents. This may pose a greater risk of 
transmission of the bacteria. The close contact of humans and animals in pastoral areas also 
enhances transmission of the bacteria (Cacciapuoti, Nuti, Pinto, et al., 1982) which could 
be picked up in animal carriers through urine contamination of scarce water points. The 
observation from the DDDAC project of higher seroprevalence in pastoralist communities 
when compared to those from the irrigated areas also corroborate this finding (Bett, Said, 
Sang, et al., 2015). Collection of human samples in the DDDAC project was done in the 
same areas and time as those of this study. Results from this study however could be 
confounded by the fact that samples in the irrigated areas were collected when irrigation 
was on-going (wet season) and the pastoral areas during dry season. Future studies should 
factor in seasonality in the analysis of samples. There will also be great benefit to 
demonstrate the bacteria and local serotypes in domestic animals so as to elucidate the risk 
of transmission of the disease in the areas as well as know the circulating serotypes.  
Land use changes have been linked to disease emergence in many parts of the world, with 
anthropogenic activities like irrigation, road construction, agricultural encroachment, 
wetland modification, deforestation, dam building, mining, coastal zone degradation and 
development of urban environments acting as drivers of disease (Patz, Daszak, Tabor, et 
al., 2004). Maintenance of the bacteria in irrigated areas may be enhanced by the observed 
rise in populations of rodents as well as loss of tree cover and bush lands with increase in 
irrigated/cultivated land (Bett, Said, Sang, et al., 2015; Ontiri, Bett, Lindahl, et al., 2014). 
A rise in population of rodents habouring the bacteria could lead to increased disease 
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incidence among human and livestock populations. Investigation of land use changes and 
disease incidence in future will therefore greatly advise policy makers on the benefits and 
dangers of large-scale economic activities in rural populations and better inform control 
strategies that will cause no harm to human health and livelihoods. 
Health inequities are also rife in these two counties. Key gaps in the health systems in 
Garissa include long distance to health facilities coupled with a lack of adequate 
transportation services and amenities, lack of hospital supplies and equipment, poor 
condition of hospital facilities, severe shortage of human resources for health (HRH) and 
limited services being offered. Basic diagnostic services are not available in the vast 
unpopulated area of the county except in the provincial general hospital in Garissa town 
(APHIAplusNAL, 2012). Similar inequities can be observed in Tana River County.  
Because of this, there is need for strengthening of health systems in these areas so as to 
cater for emerging zoonotic diseases whose effect is felt the most by the impoverished. 
Proper diagnosis of such diseases at an early stage and early treatment with simple 
antibiotics will greatly curtail debilitating effects of leptospirosis and any sequelae. This 
also applies to animal leptospirosis which when diagnosed and treated early does not give 
rise to reproductive wastage in livestock. Studies such as this will inform public and animal 
health policy on the risk posed by such ‘silent diseases’ as leptospirosis. 
Garissa has in the past had its fair share of insecurity, with the latest being the gruesome 
Garissa University College terrorist attack, and collection of samples for study is largely 
dependent on the prevailing peace. This, coupled with the remoteness of the area may 
explain the few studies that have been carried out in the area. This pilot study however has 
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not only demonstrated the disease in rodent carriers but also shown the feasibility of future 
studies in the counties. 
6.2 Recommendations  
 
There is need to explore more animal hosts from the study areas and demonstrate the 
circulating serotypes in the area. A one-health approach that considers human populations, 
domestic animals and wildlife will do the best in understanding the complicated 
transmission dynamics in areas that under the force of dynamic disease drivers.  
PCR primers used in this study are known to confidently detect all pathogenic leptospires 
with the exception of L. kirschneri species. The G1/G2 primers used were not coupled with 
the L. kirschneri-specific B64I/B64II primers (Gravekamp, Van de Kemp, Franzen, et al., 
1993) due to lack of funding for this as well as a lack of positive control. The pathogenic 
leptospires may therefore be understated in this respect and future studies would better 
inform on prevalence of the disease if both primers are used. 
Though this study utilized a small sample size, it is one of the few that has demonstrated 
the presence of the bacteria in rodent carriers in these remote areas of Kenya. This 
demonstrates the understated public health importance of leptospirosis in these areas. The 
use of a sample size that is more statistically representative of the number and species of 
rodents in the area will also reveal more on these rodent carriers of the disease. 
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Appendix 1 
1. Preparation of 50X TAE buffer 
Needed 
242g Tris Base (MW=121.1) 
57.1ml Glacial Acetic Acid 
100ml 0.5M EDTA 
 
i. Measure Tris powder into reagent bottle and dissolve with 700ml of distilled 
water. Mix using a stir bar and a magnetic stirrer. 
ii. Add glacial acetic acid and EDTA solution  
iii. Top up the volume to 1L 
To make 10L of 0.5X working solution, take 100ml of stock solution and top up to the 10L 
mark. 
 
2. Preparing a 2% 100ml agarose gel 
i. Assemble the gel tray and combs for creating the well. Ensure the platform for 
gel polymerization flat by using a leveler. 
ii. Measure 2g of agarose powder and add 100ml of working solution of TAE 
buffer in a conical flask 
iii. Melt the agarose and let it cool down 
iv. Add 5µl of GelRed™ dye (Biotium, Hayward, CA, USA) 
v. Pour into the gel tank and let it polymerize 
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Appendix 2 
Table A1: Results of diagnostic analyses of samples analyzed using PCR test. 
Sample ID Sample type Rodent ID RESULTS ng/µl 260/280 Selected for sequencing 
TID001053 Blood BRA IJ01 Negative 2.84 0.057  
TID001048 Kidney BRA IJ01 Positive 41.04 0.821 * 
TID001076 Kidney BRA IJ02 Positive 155 3.1 * 
TID001054 Kidney BRA IJ03 Negative 8.61 0.172  
TID001021 Kidney BRA IJ05 Weak Positive 13.41 0.268  
TID001012 Blood BRA IJ06 Positive 5.78 0.116  
TID001031 Kidney BRA IJ06 Positive 43.81 0.876  
TID001051 Kidney BRA IJ07 Positive 54.59 1.092 * 
TID001024 Kidney BRA IJ08 Positive 25.48 0.51  
TID001137 Kidney BRA IJ09 Positive 101.73 2.035 * 
TID001118 Blood BRA IJ10 Positive 117.18 2.344 * 
TID001177 Kidney BRA IJ10 Negative 31.69 0.634  
TID001213 Blood BRA IJ11 Negative 7.53 0.151  
TID001123 Kidney BRA IJ11 Negative 20.97 0.419  
TID001057 Kidney BRA IJ12 Positive 26.07 0.521  
TID001011 Blood BRA IJ13 Negative 5.93 0.119  
TID001211 Kidney BRA IJ13 Weak Positive 19.23 0.385  
TID001281 Kidney BRA IJ14 Negative 11.43 0.229  
TID001292 Kidney BRA IJ15 Negative 36.08 0.722  
TID001187 Kidney BRA IJ16 Weak Positive 26.4 0.528  
TID001282 Blood BRA IJ18 Negative 4.75 0.095  
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Sample ID Sample type Rodent ID RESULTS ng/µl 260/280 Selected for sequencing 
TID001245 Kidney BRA IJ18 Negative 39.93 0.799  
TID001330 Blood BRA IJ19 Positive 17.52 0.35  
TID001229 Kidney BRA IJ19 Negative 11.51 0.23  
TID001231 Blood BRA IJ20 Negative 4.54 0.091  
TID001234 Kidney BRA IJ20 Positive 71.1 1.422  
TID001251 Kidney BRA IJ21 Negative 61.83 1.237  
TID000029 Blood BRA1482 Negative 92.23 1.845  
TID000031 Kidney BRA1482 Positive 333.48 6.67  
TID000037 Blood BRA1483 Negative 15.97 0.319  
TID000044 Blood BRA1484 Negative 130.95 2.619  
TID000099 Blood BRA1485 Negative 365.64 7.313  
TID000504 Kidney BRA1485 Positive 253.14 5.063  
TID000068 Blood BRA1486 Positive 63 1.26  
TID000064 Blood BRA1487 Positive 33.71 0.674  
TID000055 Blood BRA1488 Negative 14.19 0.284  
TID000497 Kidney BRA1489 Positive 235.42 4.708 * 
TID000054 Blood BRA1489 Negative 235.42 4.708  
TID000507 Blood BRA1490 Negative 102.42 1.98  
TID000496 Blood BRA1491 Negative 45.84 1.91  
TID000137 Blood BRA1492 Negative 109.97 2.02  
TID000058 Kidney BRA1493 Positive 280.17 5.603  
TID000479 Blood BRA1494 Weak Positive 81.13 2.07  
TID000370 Blood BRA1495 Negative 42.95 1.87  
TID000210 Blood BRA1496 Negative 59.91 2.01  
TID000200 Blood BRA1497 Negative 96.32 1.95  
TID000516 Blood BRA1498 Negative 51.39 1.99  
TID000241 Kidney BRA1499 Positive 8.19 1.22  
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Sample ID Sample type Rodent ID RESULTS ng/µl 260/280 Selected for sequencing 
TID000179 Blood BRA1499 Negative 251.98 2.06  
TID000177 Blood BRA1500 Negative 121.89 2.438  
TID000189 Blood BRA1501 Negative 42.58 0.852  
TID000240 Blood BRA1502 Negative 52.78 1.056  
TID000243 Blood BRA1503 Negative 138.94 2.779  
TID000202 Blood BRA1504 Negative 83.74 1.675  
TID000375 Blood BRA1505 Negative 108.9 2.178  
TID000201 Blood BRA1506 Negative 21.05 0.421  
TID000383 Blood BRA1507 Negative 162.63 3.253  
TID000217 Blood BRA1508 Negative 302.88 6.058  
TID000387 Blood BRA1509 Weak Positive 1041.72 20.834  
TID000215 Blood BRA1510 Negative 653.67 13.073  
TID000213 Blood BRA1511 Negative 77.39 1.548  
TID000378 Blood BRA1512 Negative 78.83 1.577  
TID000368 Blood BRA1513 Negative 278.62 5.572  
TID000173 Blood BRA1514 Negative 281.03 5.621  
TID000386 Blood BRA1515 Positive 513 10.26  
TID000662 Blood BRA1516 Positive 111.3 2.226  
TID000611 Blood BRA1517 Negative 212.94 4.259  
TID000220 Blood BRA1518 Negative 176.06 3.521  
TID000697 Blood BRA1519 Negative 84.22 1.684  
TID000694 Blood BRA1520 Negative 36.75 0.735  
TID000673 Blood BRA1521 Negative 226.12 4.522  
TID000667 Blood BRA1522 Negative 36.32 0.726  
TID000708 Blood BRA1523 Negative 71.72 1.434  
TID000702 Blood BRA1524 Positive 17.61 0.352  
TID000661 Blood BRA1525 Negative 10.27 0.205  
TID001092 Kidney BRA1527 Positive 5.26 0.105  
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Sample ID Sample type Rodent ID RESULTS ng/µl 260/280 Selected for sequencing 
TID001073 Blood BRA1528 Positive 6.2 0.124  
TID001090 Kidney BRA1528 Negative 16.73 0.335  
TID001038 Kidney BRA1529 Weak Positive 10.95 0.219  
TID001022 Kidney BRA1530 Negative 13.53 0.271   
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